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Inappropriate inflammasome activation contributes
to multiple human diseases, but the mechanisms
by which inflammasomes are suppressed are poorly
understood. The NF-kB inhibitor A20 is a ubiquitin-
modifying enzyme that might be critical in preventing
human inflammatory diseases. Here, we report
that A20-deficient macrophages, unlike normal cells,
exhibit spontaneous NLRP3 inflammasome activity
to LPS alone. The kinase RIPK3, but not the adaptor
MyD88, is required for this response. In normal cells,
A20 constitutively associates with caspase-1 and
pro-IL-1b, and NLRP3 activation further promotes
A20 recruitment to the inflammasome. Pro-IL-1b
also co-immunoprecipitates with RIPK1, RIPK3,
caspase-1, and caspase-8 in a complex that is modi-
fied with K63-linked and unanchored polyubiquitin.
In A20-deficient macrophages, this pro-IL-1b-asso-
ciated ubiquitination is markedly increased in a
RIPK3-dependent manner. Mass spectrometric and
mutational analyses reveal that K133 of pro-IL-1b is
a physiological ubiquitination site that supports pro-
cessing. Our study reveals a mechanism by which
A20 prevents inflammatory diseases.
INTRODUCTION
Secretion of the pro-inflammatory cytokines interleukin-1b
(IL-1b) and IL-18 is normally regulated by at least two distinct
signals (Martinon et al., 2002). First, expression of the inactive
pro-proteins requires nuclear factor-kB (NF-kB) activity trans-
duced by pattern-recognition receptors (PRRs) such as Toll-
like receptors (TLRs). Subsequently, the proteolytic processing
of these cytokines usually requires caspase-1 (Casp1) activation
by cytosolic PRRs possessing a pyrin domain and/or caspase
activation and recruitment domain (CARD) (Davis et al., 2011;
Martinon et al., 2009). Upon detecting the presence of microbes
or ‘‘danger signals,’’ these proteins recruit Casp1 either directly
or via the adaptor protein, ASC (apoptosis-associated speck-
like protein containing a C-terminal CARD), to form a signalingcomplex called the inflammasome. Though critical for efficient
pathogen clearance, exaggerated inflammasome functions can
play pathogenic roles in various autoimmune, allergic, and
inflammatory disorders (Lamkanfi and Dixit, 2012; Strowig
et al., 2012). The mechanisms by which inflammasomes are
regulated are incompletely understood.
The NLRP3 (nucleotide-binding domain and leucine-rich
repeats containing pyrin domain 3) inflammasome is normally
induced by large particulates such as uric acid crystals, choles-
terol crystals, amyloid or misfolded protein, and asbestos (Lee-
mans et al., 2011). Exaggerated activities of NLRP3 to these
particulates are implicated in the pathogenesis of gout, type-
2 diabetes, atherosclerosis, neurodegenerative diseases, and
asthma (Davis et al., 2011). How NLRP3 responds to such
diverse stimuli is incompletely understood but might involve
lysosomal rupture, reactive oxygen species (ROS), or mito-
chondrial damage (Leemans et al., 2011). The loss of intra-
cellular K+ ions appears to be required, as blocking K+ efflux
suppresses NLRP3 activities (Mun˜oz-Planillo et al., 2013).
NLRP3 can also sense cellular damage from within or nearby
cells by the release of ATP, which causes K+ efflux through
the P2X7 channel (Mariathasan et al., 2006). In response to
Gram-negative bacteria, NLRP3 activation also requires the
upregulation of Casp11 by type I interferons (IFNs) (Kayagaki
et al., 2011; Rathinam et al., 2012). Although several molecules
required for inflammasome activation have been described,
inhibitors of these protein complexes have not been completely
defined.
Covalent conjugation of ubiquitin (Ub) molecules to target
proteins, termed ubiquitination, regulates protein stability and
protein-protein interactions in signaling complexes. Poly-Ub
chains can be linked via N-terminal amino groups on Met1
(termed linear chains) or via ε-amino groups on any of the seven
lysines of Ub. These distinct poly-Ub conformations are recog-
nized by specific Ub sensor proteins that facilitate the localiza-
tion, activity, and interacting partners of ubiquitinated proteins
(Corn and Vucic, 2014). In particular, K48-linked poly-Ub chains
generally target proteins for proteasomal degradation, whereas
linear and K63-linked chains primarily serve as a scaffolding
network for the formation of signaling complexes.
A20, encoded by the tumor necrosis factor-a (TNF-a)-induced
protein 3 (TNFAIP3) gene, is a potent regulator of Ub-dependent
signaling (Shembade and Harhaj, 2012; Verstrepen et al.,
2010). Polymorphisms in the human TNFAIP3 gene locus areImmunity 42, 55–67, January 20, 2015 ª2015 Elsevier Inc. 55
Figure 1. A20 Deficiency Causes Secretion
of Mature IL-1b in the Absence of an Exoge-
nous Second Signal for InflammasomeActi-
vation
(A–C) BMDMs cultured from WT or Tnfaip3/
mice were stimulated with the following ligands for
15 hr: 10 mg/mL Zym, 100 mg/mL poly(I:C) (P(I:C)),
500 ng/mL LPS, 3 mg/mL Gdq, and 5 mM CpG. (A)
Supernatants were analyzed by ELISA for IL-1b
secretion. (B) Whole-cell lysates were analyzed by
IB for the indicated proteins after 6 hr stimulation
of each ligand as in (A). (C) IL-1b was IP’d from
supernatants and analyzed by IB to confirm pro-
teolytic processing.
(D) IL-1b secretions by Tnfaip3/ BMDMs in
response to 500 ng/mL LPS for 0–18 hr, or 0–
500 ng/mL LPS for 18 hr, were quantitated by
ELISA.
(E) IL-1b secretions in response to Dectin-1, TLR3,
and TLR4 ligands by A20-sufficient and -deficient
BMDMs on Myd88/ background were
measured after 15 hr. Note TLR2 cannot
respond to Zym without MyD88.
(F) IL-1b secretions by A20-deficient cells after
15 hr of TNF-a or anti-CD40 stimulation were
measured.
(G) Supernatant from A20-deficient cells stimu-
lated with LPS for 15 hr (bottom of graph) was
transferred to LPS-primed control cells. After
overnight incubation, the supernatant was
measured again for any additional IL-1b secretion
by control cells. As controls for NLRP3 respon-
siveness, IL-1b responses to ATP by control cells
in the presence or absence K+ efflux were
measured. To eliminate any potential complica-
tions by autocrine TNF-a signaling, both control
and A20-deficient cells used here were on Tnf/
background. Each bar in graphs represents mean
of triplicate wells + SD. * denotes statistical sig-
nificance by Student’s t test (p < 0.05) when
comparison is made between control and A20-
deficient cells for each condition. n.s. = not sta-
tistically significant. All data presented here and
hereafter are representative of at least three in-
dependent experiments.associated with a number of inflammatory diseases, suggesting
that A20 prevents the incidence and/or severity of these
diseases (Catrysse et al., 2014; Ma and Malynn, 2012). Corre-
spondingly, A20-deficient mice spontaneously develop a sys-
temic inflammatory syndrome that culminates in premature
death (Lee et al., 2000), while cell-specific deletions of A20 cause
diseases in mice reminiscent of those in humans (Chu et al.,
2011; Hammer et al., 2011; Heger et al., 2014; Kool et al.,
2011; Matmati et al., 2011; Tavares et al., 2010; Vereecke
et al., 2010). Deficiency inMyD88 (myeloid differentiation primary
response 88) or commensal depletion abrogates the severity of
several of these conditions, indicating that A20 restricts TLR
and IL-1-receptor (IL-1R) family signaling (Boone et al., 2004;
Turer et al., 2008). Hence, A20 appears critically positioned at
the interface of host responses to commensal microbes. Given
the genetic links between inflammasomes and A20 with human
inflammatory diseases, we have investigated the potential role
of A20 in regulating inflammasomes.56 Immunity 42, 55–67, January 20, 2015 ª2015 Elsevier Inc.RESULTS
A20 Prevents Spontaneous Secretion of IL-1b and IL-18
To determine whether A20 regulates inflammasome activity,
we stimulated bone marrow-derived macrophages (BMDMs)
from Tnfaip3/ and control mice with various TLR ligands.
Consistent with the two-signal requirement for IL-1b secretion
(Martinon et al., 2002), TLR ligands alone induced only the
intracellular expression of pro-IL-1b in wild-type (WT) cells (Fig-
ures 1A and 1B). No mature IL-1b was detected in the super-
natants (Figure 1A). Surprisingly, even without a second signal
for inflammasome activation, Tnfaip3/ BMDMs secreted
IL-1b in response to zymosan (Zym), poly(I:C), and LPS (Fig-
ure 1A). Similar results were obtained for the secretion of
IL-18 (data not shown). Other TLR ligands induced the expres-
sion of pro-IL-1b in both Tnfaip3/ and WT cells but failed
to induce its processing and secretion (Figures 1B and 1A).
To determine whether the secreted IL-1b was proteolytically
mature, we immunoprecipitated (IP’d) IL-1b from the superna-
tants of TLR-stimulated Tnfaip3/ cells and assessed the
molecular weight of the secreted IL-1b by immunoblotting
(IB). These experiments confirmed the IL-1b secretion in each
case to be the processed 17 kDa form (Figure 1C). The secre-
tion of IL-1b from Tnfaip3/ cells was detected as early as
2 hr after LPS stimulation and at LPS doses as low as
5 ng/mL (Figure 1D). Thus, A20 prevents spontaneous pro-IL-
1b processing and secretion in cells stimulated with Zym,
poly(I:C), and LPS.
Zymosan can activate MyD88-dependent as well as-indepen-
dent pathways through TLR2 and Dectin-1, respectively (Brown
et al., 2002; Underhill et al., 1999), and both MyD88 and TRIF
(TLR/IL-1R domain-containing adaptor inducing IFN) are
involved in TLR4 responses to LPS (Hoebe et al., 2003). We
therefore assessed the contribution of MyD88 to the sponta-
neous IL-1b secretion induced by these ligands in Tnfaip3/
cells. Tnfaip3/Myd88/ cells retained the ability to process
and secrete IL-1b upon Zym or LPS stimulation (Figure 1E). Pre-
dictably, the IL-1b responses of A20-deficient cells to poly(I:C)
were unaffected by MyD88 deficiency, because TLR3 uses
only TRIF to signal (Figure 1E). Hence, TRIF-dependent signals
and other MyD88-independent signals are sufficient to drive
pro-IL-1b processing in the absence of A20. To determine
whether other MyD88-independent signals beside TLR3 and
Dectin-1 could induce IL-1b secretion, we stimulated Tnfaip3/
cells with TNF-a or agonistic anti-CD40 antibody. We found that
anti-CD40, but not TNF-a, triggered IL-1b secretion in these cells
(Figure 1F). Additionally, TNF-a deficiency had no effects on
IL-1b secretion by A20-deficient cells in response to all of these
stimuli (data not shown), ruling out involvement of TNF-a auto-
crine signaling.
TLR3 and TLR4 can trigger programmed necrosis under
certain conditions (Feoktistova et al., 2011; He et al., 2011;
Kaiser et al., 2013). Thus, secretion of IL-1b by Tnfaip3/ cells
could result from the release of danger-associated molecular
patterns (DAMPs) by dying cells (e.g., ATP) to activate inflamma-
somes. To test whether Tnfaip3/ cells might release such
ligands, we stimulated LPS-primed control BMDMs with super-
natants from LPS-stimulated Tnfaip3/ cells and assayed for
additional IL-1b production by control cells. We found that
Tnfaip3/ BMDM-derived supernatant failed to stimulate addi-
tional IL-1b secretion from Tnfaip3+/+ cells (Figure 1G). In
contrast, addition of ATP to these cells induced robust IL-1b
secretion that could be inhibited by preventing K+ efflux, as
predicted for NLRP3 activation (Figure 1G). Taken together,
these experiments suggest that A20 suppresses spontaneous
IL-1b production in a cell-autonomous fashion.
A20 Suppresses NLRP3 Inflammasome Functions
We next determined whether A20 could also inhibit NLRP3
responses to a second signal. Addition of ATP to A20-deficient
cells after 4 hr of LPS stimulation induced massive IL-1b secre-
tion compared to WT cells (Figure 2A). Hence, A20 limits the
magnitude of NLRP3 inflammasomes triggered by LPS plus
ATP, aswell as preventing spontaneous IL-1b secretion. Besides
cleaving pro-IL-1b/18, overt Casp1 activity can also cause
pyroptosis, an inflammatory form of lytic cell death (Davis
et al., 2011). Accordingly, considerably more Tnfaip3/ cellsdied in response to LPS plus ATP than control cells (Figure 2B).
These results indicate that A20 also restricts pyroptosis induced
by NLRP3 inflammasome activation. Of note, the amounts of cell
death did not differ between WT and Tnfaip3/ cultures in
response to LPS alone (Figure 2B), confirming that Tnfaip3/
cells did not die necrotically and release DAMPs as second sig-
nals for inflammasome activation (Figure 1G).
NLRP3, ASC, and Casp1 are all critical components of inflam-
masomes. To assess the potential contributions of each of these
proteins to the spontaneous IL-1b secretion observed in
A20-deficient cells, we interbred Tnfaip3/ mice with Nlrp3/,
Asc/, and Casp1/11/ mice. BMDMs from all three com-
pound mutant strains secreted 65%–100% less IL-1b than
Tnfaip3/ cells after stimulation with poly(I:C), LPS, or Zym (Fig-
ures 2C–2E). These results indicate that A20 restricts the sponta-
neous assembly of NLRP3 with ASC and Casp1 in response to
these stimuli. Because Casp1-deficient mice also harbor mutant
Casp11 allele from 129 strain (Kayagaki et al., 2011), the residual
mature IL-1b secretions by Tnfaip3/Casp1/11/ compound
mutant cells indicate that A20-deficient cells can additionally
process pro-IL-1b through a mechanism that is independent of
both Casp1 and Casp11 (Figures 2C and 2E; data not shown).
Depletion of all three baculoviral inhibitor of apoptosis protein
(IAP) repeat-containing enzymes (BIRC2, BIRC3, and BIRC4) in
BMDMs has been reported to result in spontaneous NLRP3
inflammasome activation by a RIPK3 (receptor-interacting pro-
tein kinase 3)-dependent mechanism (Vince et al., 2012). We
thus asked whether a similar pathway was responsible for
the spontaneous NLRP3 activation in A20-deficient cells. We
interbred Tnfaip3/mice with Ripk3/ mice and assayed their
BMDMs for inflammasome activity. Tnfaip3/Ripk3/ double
mutant BMDMs exhibited drastically reduced IL-1b secretion in
response to poly(I:C), LPS, or Zym when compared to
Tnfaip3/ cells (Figure 2F). Thus, RIPK3 is critical for the spon-
taneous NLRP3 activity in A20-deficient cells.
A20 Restricts NLRP3 Activity Independently of Its Role
in NF-kB Regulation
The expression of both pro-IL-1b (Figure 1B) and NLRP3 is
induced by NF-kB activation (Bauernfeind et al., 2009). As A20
restricts TLR-induced NF-kB signaling (Boone et al., 2004; Turer
et al., 2008), we determined whether the spontaneous NLRP3
inflammasome activity in A20-deficient cells results from
increased pro-IL-1b or NLRP3 expression. We noted the
amounts of pro-IL-1b expressed in WT and Tnfaip3/ cells
induced by various TLR ligands correlated poorly with the
amounts of secreted mature IL-1b (Figures 1A and 1B). For
example, poly(I:C) stimulation induced much less pro-IL-1b
expression than CpG or gardiquimod (Gdq) from Tnfaip3/ cells
(Figure 1B); yet, poly(I:C) induced robust IL-1b secretion while
Gdq and CpG did not (Figures 1A and 1C). More dramatically,
poly(I:C) induced much less pro-IL-1b expression in Tnfaip3/
cells than WT cells stimulated with Zym, LPS, Gdq, or CpG
(Figure 1B); yet, poly(I:C)-stimulated Tnfaip3/ cells readily pro-
cessed pro-IL-1b for secretion while WT cells failed to do so with
all TLR ligands tested (Figures 1A and 1C). We next assayed for
NLRP3 expression in control and Tnfaip3/ cells in response to
various TLR ligands. The NLRP3 expression patterns paralleled
those of pro-IL-1b (Figure S1A). These data strongly suggestImmunity 42, 55–67, January 20, 2015 ª2015 Elsevier Inc. 57
Figure 2. Spontaneous NLRP3 Activity in Tnfaip3–/– Cells Depends on RIPK3
(A and B) As shown in (A), IL-1b responses by WT or Tnfaip3/ BMDMs to ATP were measured by ELISA. Cells were pre-stimulated with LPS for 4 hr (IL-1b
secretions displayed on left of graph), followed by 30 min pulse with 5 mM ATP. Three hr after addition of fresh media, IL-1b responses were measured (right of
graph). (B) Pyroptotic responses to ATP were measured by LDH (lactate dehydrogenase) release assays.
(C–E) Effects of NLRP3, ASC, or Casp1/Casp11 deficiency on IL-1b secretion by Tnfaip3/ cells were assessed. Single and compoundmutants were stimulated
with the indicated ligands for 15 hr (C and D) or with 500 ng/mL LPS for the indicated time (E). The ligands used in (C) and (D) were 1 mg/mL Pam3CSK4
(P3CSK4), 100 mg/mL poly(I:C), 500 ng/mL LPS, 100 ng/mL flagellin (Flag), 3 mg/mL Gdq, and 5 mM CpG.
(F) Effects of RIPK3 deficiency on IL-1b responses by A20-deficient cells to poly(I:C), LPS, and Zymwere assessed by ELISA. Each bar in graphs representsmean
of triplicate wells + SD. * denotes statistical significance (p < 0.05) when comparison is made between control and A20-deficient cells for each condi-
tion. # denotes statistical significance by Student’s t test (p < 0.05) when comparison is made between A20 deficiency alone with the indicated compound
mutations.s denotes statistically significant contribution byNLRP3, ASC, or Casp1 andCasp11 functions to spontaneous IL-1b secretion by A20-deficient cells.that A20 regulates NLRP3 activity in a manner separate from
regulating pro-IL-1b and NLRP3 transcription.
Both TRIF and MyD88 adaptor molecules participate in TLR4
signaling (Hoebe et al., 2003). Hence, we determined to what
extent MyD88 deficiency might reduce the NLRP3 and pro-
IL-1b expression in A20-deficient cells. Upon LPS stimulation,
MyD88 deficiency decreased the amounts of NLRP3 and pro-
IL-1b proteins in Tnfaip3/Myd88/ cells to those of WT cells58 Immunity 42, 55–67, January 20, 2015 ª2015 Elsevier Inc.(Figure S1B). Yet, Tnfaip3/Myd88/ cells secreted mature
IL-1b in response to LPS (Figure 1E), whereas WT cells did not
(Figure 1A). These data suggest that A20 restrains a TRIF-depen-
dent signal that can otherwise cause aberrant NLRP3 activation.
Unlike Tnfaip3/ single mutant cells, Tnfaip3/Ripk3/
compound mutant cells secreted little, if any, processed IL-1b
(Figure 2F). Although RIPK3 has been reported to play no roles
in TLR-induced transcriptional responses (Newton et al., 2004),
Figure 3. A20 Associates with Pro-IL-1b
Complex Consisting of Casp1, Casp8,
RIPK1, and RIPK3
(A) BMDMs cultured from WT, Tnfaip3/, or
casp1/11/mice were stimulated with 500 ng/mL
LPS for 0–6 hr, lysed, and subjected to Casp1 IP,
followed by IB analyses for A20 and pro-IL-1b
interaction. Input for each IP is shown on the right.
(B) Pro-IL-1b was IP’d from lysates of control and
A20-deficient BMDMs stimulated with 500 ng/mL
LPS for 0–12 hr. Co-association of each indicated
protein with pro-IL-1bwas analyzed by IB. Input IB
analyses are shown on the right.
(C) Control and A20-deficient cells were stimu-
lated with LPS for 6 hr, followed by 5 mM ATP for
30 min. Pro-IL-1b IPs were performed as in (B) to
assay for changes in the interaction of each indi-
cated protein with pro-IL-1b. To avoid potential
complications by TNF-a autocrine signaling to the
assays in (B) and (C), control and A20-deficient
cells on Tnf/ background were used. Similar
results have been obtained using cells on Tnf+/+
background. Arrows indicate cleaved RIPK1.we entertained the possibility that RIPK3 deficiency might aber-
rantly affect the NF-kB-induced transcriptional responses
in A20-deficient cells. We found the kinetics and magnitudes
of LPS-induced IkBa phosphorylation and degradation
to be similar between Tnfaip3/ single mutant and Tnfaip3/
Ripk3/ compound mutant cells (Figure S1C). Moreover,
Tnfaip3/Ripk3/ cells expressed similar amounts of pro-IL-
1b and NLRP3 as Tnfaip3/ single mutant cells (Figure S1C).
Taken together, these observations suggest that A20 inhibits a
TRIF- and RIPK3-dependent step in NLRP3 inflammasome acti-
vation that is distinct from TLR-triggered transcription.
A20 Interacts with Inflammasome Proteins
Our observations that A20 restricts LPS-induced spontaneous
NLRP3 activation independently of its inhibitory role in NF-kB
signaling suggest that A20 might directly act on inflamma-Immunity 42, 55–6somes. To investigate whether A20 as-
sociates with inflammasome proteins,
we IP’d Casp1 from BMDMs stimulated
with LPS for 2–6 hr and immunoblotted
for A20. Inducible interaction between
Casp1 and A20 was evident upon LPS
stimulation alone that was not detected
in LPS-stimulated Casp1/11/ BMDMs
(Figure 3A). To further investigate A20
interaction with inflammasome proteins,
we IP’d pro-IL-1b from LPS-stimulated
control and Tnfaip3/ cells. Remark-
ably, A20 also co-IP’d with pro-IL-1b
from Tnfaip3+/+ lysates, with maximal
association occurring 3 hr after LPS
stimulation (Figure 3B). The presence
of cleaved IL-1b was also evident in the
Tnfaip3/ IPs (Figure 3B). As we
observed exaggerated NLRP3 activities
in A20-deficient BMDMs to LPS plusATP stimulation (Figures 2A and 2B), we asked whether ATP
stimulation induces additional A20 recruitment to pro-IL-1b.
We found that LPS-primed control cells recruited more A20 to
pro-IL-1b within 15 min of ATP addition (Figure 3C). Blocking
K+ efflux had minimal effect on the A20-pro-IL-1b associa-
tion, suggesting that A20 is recruited to pro-IL-1b prior to
P2X7-induced NLRP3 activation. Hence, A20 interacts with
pro-IL-1b after LPS stimulation, and NLRP3 inflammasome acti-
vation by ATP further enhances these interactions.
Unexpectedly, the IP experiments above also revealed Casp1-
pro-IL-1b pre-association in WT cells (Figures 3A, 3B, 3C),
despite the absence of pro-IL-1b processing (Figure 1A). We
also found Casp8, RIPK1, and RIPK3 to be present in this com-
plex (Figures 3B and 3C). Since RIPK3 is necessary for the spon-
taneous secretion of IL-1b by A20-deficient cells (Figure 2F),
these intriguing results suggest that (1) pro-IL-1b pre-associates7, January 20, 2015 ª2015 Elsevier Inc. 59
with Casp1 prior to inflammasome activation and (2) the absence
of A20 allows for this complex to proceed with pro-IL-1b pro-
cessing in a RIPK3-dependent manner. We thus determined
the functional consequences of A20 deficiency on this complex.
More Casp1, Casp8, and RIPK1 were associated with pro-IL-1b
in A20-deficient cells (Figures 3B and 3C). A fraction of RIPK1
was cleaved in pro-IL-1b complexes from A20-deficient cells,
suggesting the presence of active Casp8 (Figure 3B, arrows),
because RIPK1 is a Casp8 substrate (Humphries et al., 2014).
This observation is consistent with the increased active (cleaved)
Casp8 in the lysates (Figure 3B). Because Casp8 can cleave pro-
IL-1b (Bossaller et al., 2012; Gringhuis et al., 2012; Gurung et al.,
2014; Maelfait et al., 2008; Vince et al., 2012), the active Casp8 in
this complex might be responsible for the residual IL-1b secre-
tion by Tnfaip3/Casp1/11/ cells (Figures 2C and 2E). This
possibility was supported by our observation that this residual
IL-1b secretion was inhibited by the Casp8 inhibitor, Z-IETD-
FMK (data not shown). Finally, ATP stimulation of either control
or A20-deficient cells following LPS caused markedly more
IL-1b cleavage, but did not augment Casp1 or Casp8 association
with pro-IL-1b (Figure 3C). Hence, ATP activates—and A20
inhibits—the activities of Casp1 and/or Casp8 molecules that
are pre-bound to pro-IL-1b.
RIPK1 Catalytic Activity Promotes Spontaneous
pro-IL-1b Processing in A20-Deficient Cells
RIPK3 activation usually requires the kinase activity of RIPK1
during programmed necrosis (Humphries et al., 2014). As we
observed a requirement for RIPK3 in the spontaneous pro-IL-
1b processing by A20-deficient cells (Figure 2F), as well as
the presence of RIPK1 in the pro-IL-1b complex (Figures 3B,
3C, 4D), we asked whether RIPK1 activity is similarly required.
Treatment of A20-deficient cells with LPS plus the RIPK1
inhibitor, necrostatin-1 (Nec1) (Degterev et al., 2008), reduced
pro-IL-1b processing in a dose-dependent manner (Figure S2A).
To determine whether the RIPK1 activity is accompanied
by formation of RIPK1-RIPK3 complexes, or ripoptosomes
(Feoktistova et al., 2011; Tenev et al., 2011), we IP’d RIPK1
from LPS-stimulated control and A20-deficient cells. More
pro-IL-1b was co-IP’d with RIPK1 from A20-deficient cells
(Figure S2B), confirming the RIPK1-pro-IL-1b association
observed by pro-IL-1b IPs (Figures 3B and 3C). However, no
increased RIPK1-RIPK3 interaction was observed regardless
of LPS stimulation (Figure S2B). Taken together, our data sug-
gest that A20 inhibits RIPK1 association with pro-IL-1b and that
RIPK1 catalytic activity and RIPK3 drive spontaneous pro-IL-
1b processing in A20-deficient cells without ripoptosome
formation.
Pro-IL-1b Complex Contains K63-Linked and
Unanchored Poly-Ub
Because A20 restricts NF-kB signaling by modifying Ub chains
on key signaling proteins, we investigated whether inflamma-
some activation involves ubiquitination. We IP’d pro-IL-1b from
LPS-stimulated WT or Tnfaip3/ cells and probed for Ub. A
high molecular weight complex containing Ub was evident in
pro-IL-1b IPs from both WT and Tnfaip3/ BMDMs (Figure 4A).
Longer exposures of IL-1b immunoblot following pro-IL-1b IPs
also revealed that pro-IL-1b itself is modified by high molecular60 Immunity 42, 55–67, January 20, 2015 ª2015 Elsevier Inc.weight moieties with laddering patterns suggestive of ubi-
quitination (Figure 4A, middle panel). Strikingly, ATP robustly
augmented the formation of this Ub-containing complex in
both control and A20-deficient cells (Figure 4B, left panel, 3rd
and 7th lanes), suggesting that NLRP3 inflammasomes are ubiq-
uitinated. Moreover, the pro-IL-1b complex ubiquitination was
markedly increased in A20-deficient cells (Figure 4A), and the
timing of pro-IL-1b-associated Ub signals in A20-deficient cells
correlated with the temporal increase in IL-1b secretion (Fig-
ure 1D). Preventing K+ efflux had no effects on the ATP-induced
ubiquitination (Figure 4B, left panel, 4th and 8th lanes), indicating
that the poly-Ub chains are formed prior to NLRP3 oligomeriza-
tion. Thus, these observations collectively suggest that A20
restricts pro-IL1b complex ubiquitination prior to NLRP3-ASC
inflammasome assembly.
To better characterize the pro-IL-1b complex ubiquitination in
LPS-stimulated A20-deficient cells, we utilized linkage-specific
de-ubiquitinases (DUBs) to determine the types of Ub chains
present in the pro-IL-1b complex (Mevissen et al., 2013). We first
treated pro-IL-1b IPs from these cells with the non-specific DUB
USP2 (ubiquitin carboxyl-terminal hydrolase 2). USP2 eliminated
all immunoreactive Ub from the pro-IL-1b IP, confirming that our
anti-Ub immunoblots detected ubiquitination (Figure 4C, last
lane). Much of the covalent, high molecular weight modifications
on pro-IL-1b were also eliminated by USP2 treatment, reinforc-
ing the notion that pro-IL-1b itself is modified by poly-Ub (Fig-
ure 4C). To determine whether the pro-IL-1b-associated Ub
chains contain non-degradative Ub linkages, we treated the
pro-IL-1b IPs with the K63-specific DUB AMSH (associated
molecule with a Src homology 3 domain of signal transducing
adaptor molecule) and CylD (Cylindromatosis), which cleaves
both linear and K63-linked chains (Komander et al., 2008;
2009). Both AMSH and CylD reduced the pro-IL-1b-associated
poly-Ub (Figure 4C, 2nd and 3rd lanes), indicating the presence
of K63-linked Ub chains in the pro-IL-1b complex. To determine
whether the ubiquitin chains in this complex are anchored, we
treated the pro-IL-1b IP with isopeptidase T (IsoT), a DUB
specific for unanchored chains (Wilkinson et al., 1995). IsoT
also reduced the pro-IL-1b-associated ubiquitin (Figure 4C, 4th
lane). Thus, the ubiquitin chains associated with pro-IL-1b
include unanchored, as well as K63-linked, poly-Ub, both types
known to support signal propagation by encouraging non-
degradative protein-protein interactions (Corn and Vucic, 2014;
Xia et al., 2009).
We next determined whether K48 Ub linkages exist in the
complex by probing the DUB-treated pro-IL-1b IPs with an
anti-K48-linked poly-Ub antibody. Without DUB treatment, the
presence of K48-linked poly-Ub in the pro-IL-1b complex was
clearly evident (Figure 4C, 1st lane). AMSH treatment had no
effects on the K48-linked Ub signals, confirming its specificity
for K63 linkages (Figure 4C, 2nd lane). Interestingly, IsoT treat-
ment removed much of the K48-linked Ub signals, indicating
that the majority of K48 linkages are present in unanchored
chains (Figure 4C, 4th lane). It has been reported that K48 link-
ages in unanchored poly-Ub or mixed chains can also support
positive roles in signaling independently of proteasomal degra-
dation (Jiang et al., 2012; Rajsbaum et al., 2014). Hence, the
pro-IL-1b complex is ubiquitinated with chains that can support
non-proteasomal signal propagation.
Figure 4. Pro-IL-1b in A20-Deficient Cells Associates with RIPK3-Dependent K63-Linked and Unanchored Poly-Ub
(A) WT and Tnfaip3/ BMDMs were stimulated with 500 ng/mL LPS for 0–7 hr. Pro-IL-1b IPs were performed as in Figure 3B and analyzed for Ub signals and
Casp1 interaction. Input IB analyses are shown on the right.
(B) Control and A20-deficient cells on Tnf/ background were primed with 500 ng/mL LPS for 6 hr and subsequently stimulated with 5 mM ATP for 15–20 min.
Pro-IL-1b IPs, followed by IB analyses, were performed as in Figure 3C. IB analyses of each reaction input are shown on the right.
(C) Pro-IL-1b IPs from A20-deficient BMDMs stimulated with 500 ng/mL LPS for 6 hr were subjected to DUB proteolysis. Ub signals were subsequently
analyzed by IB.
(D) Control or A20-defcient BMDMs with or without RIPK3 deficiency were stimulated with 500 ng/mL LPS for 6 hr. Subsequently, Pro-IL-1b IPs, followed by IB
analyses, were performed to assay for Ub signals and the interaction of each indicated protein with pro-IL-1b. Arrow indicates cleaved RIPK1. Note the anti-IL-1b
antibody used in IB analyses cannot recognize IL-1b that is modified by >10 Ub molecules, perhaps due to steric hindrance by the Ub modification.
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Figure 5. Overexpression of A20 Sup-
presses Casp1 Activity
(A) 293T cells seeded in 6-well plates were tran-
siently transfected with 150 ng/well of each
plasmid encoding HA-Casp1, Myc-ASC, or pro-
IL-1b linked to GFP via an IRES sequence, plus
0–50 ng/well of plasmid encoding Flag-A20. 24 hr
later, IL-1b secretions in the supernatant were
quantified by ELISA (upper left panel) and
analyzed by IB following IL-1b IP (lower left panel).
IB analyses of the transfected cell lysates are
shown on the right.
(B) 293T cells seeded in 6-cm dishes were trans-
fected with 500 ng/well of each construct for
Streptag-Casp1, Myc-ASC, and pro-IL-1b linked
to GFP via an IRES sequence. 6 mg of plasmid
encoding HA-tagged WT or K63-only Ub was also
included along with 0–50 ng/well of Flag-A20
construct. 24 hr later, cells were lysed, subjected
to pro-IL-1b IP, and analyzed by IB for the indi-
cated proteins. Input immunoblots are shown on
the right.Pro-IL-1b-Associated Ubiquitination Depends on RIPK3,
But Not NLRP3, ASC, or Casp1
Our data above suggest that ubiquitination of pro-IL-1b com-
plex correlates with inflammasome activity. As RIPK3 defi-
ciency abolished most of IL-1b secretion by A20-deficient
cells, we next determined whether rendering Tnfaip3/ cells
RIPK3 deficient would similarly affect the pro-IL-1b-associated
Ub signals. Strikingly, Tnfaip3/Ripk3/ cells displayed
markedly less ubiquitination of pro-IL-1b complex than
Tnfaip3/Ripk3+/+ cells after LPS stimulation (Figure 4D). Of
note, Tnfaip3/Ripk3/ cells also displayed reduced Casp8
activity, as indicated by the decreased presence of cleaved
Casp8, as well as its putative substrate, RIPK1 (Figure 4D,
right panel, arrow). To determine whether formation of this
ubiquitinated complex required NLRP3, ASC, or Casp1, we
tested Tnfaip3/Nlrp3/, Tnfaip3/Asc/, and Tnfaip3/
Casp1/11/ compound mutant cells in a similar fashion. In
contrast to Tnfaip3/Ripk3/ cells, ubiquitination of pro-IL-
1b complex in these compound mutant cells resembled those
seen in single mutant Tnfaip3/ cells (Figures S3A and S3C).
Furthermore, ATP stimulation of these compound mutant cells
induced similar amounts of Ub modification on pro-IL-1b com-
plexes (Figures S3A and S3B). Taken together, these data
suggest that exaggerated ubiquitination of pro-IL-1b com-
plexes in A20-deficient cells occurs downstream of RIPK3
but upstream of NLRP3, ASC, and Casp1/Casp11 inflamma-
some assembly.62 Immunity 42, 55–67, January 20, 2015 ª2015 Elsevier Inc.A20 Suppresses Casp1 Activity
Our data above suggest that A20
might act directly on inflammasome
complexes to prevent their spontaneous
activity. To test whether A20 can inhibit
Casp1 activity independently of TLR
signaling, 293T cells were transiently
transfected with expression plasmids
of ASC, Casp1, and pro-IL-1b coupled
to GFP by an IRES sequence, with orwithout A20. As previously reported (Srinivasula et al., 2002),
overexpression of ASC and Casp1 led to their self assembly,
and the resultant Casp1 activity was evident through the
secretion of mature IL-1b (Figure 5A). Importantly, co-expres-
sion of A20 dampened this process in a dose-dependent
manner (Figure 5A, left panels) without affecting GFP or
pro-IL-1b expression (Figure 5A, right panels). These results
reinforce the point that A20 can suppress pro-IL-1b process-
ing independently of the amount of pro-IL-1b expressed. We
next determined whether this Casp1 activity involves ubiquiti-
nation by including constructs for the expression of HA-
tagged WT Ub, as well as a mutant that can undergo only
K63-linked conjugation. As observed with BMDMs, K63-linked
Ub signals were detected in pro-IL-1b IPs, and overexpres-
sion of A20 dampened this signal in a dose-dependent
manner (Figure 5B). These results reinforce our data above
that A20 restricts K63-linked ubiquitination of the pro-IL-1b
complex (Figure 4C).
Ubiquitination of pro-IL-1b Supports Casp1 Proteolytic
Processing
Our finding that pro-IL-1b-associated ubiquitination in
Tnfaip3/ cells was not eliminated by NLRP3, ASC, or
Casp1/11 deficiency (Figures S3A–S3C) suggest that pro-
IL-1b itself might undergo ubiquitination. This notion is also
supported by our observation that pro-IL-1b in activated mac-
rophages is modified by high molecular weight moieties, which
Figure 6. Lys133 of pro-IL-1b Supports
Ubiquitination and Processing
(A) Tnfaip3/ BMDMs stimulated with 500 ng/mL
LPS for 6 hr were subjected tomass spectrometric
analyses. CID tandem mass spectrum was
obtained from a precursor ion with m/z value
759.0690+3, present in the pull-downs of K-ε-GG
peptides from the trypsin-digested lysates. Data-
base search identifies it as the peptide expanding
amino acids 127 to 144 of pro-IL-1b, carrying a
diglycine remnant on K133 (theoretical mono-
isotopic m/z = 759.0691+3). Expectation value for
the sequence assignment is 8.13 105. Sequence
ions are labeled in the figure and indicated
with marks over (C-terminal ions) and below
(N-terminal ions) the sequence of the peptide.
(B and C) 293T cells seeded in 6-well plates were
transiently transfected with 500 ng/well of Myc-
ASC expression plasmid, plus 500 ng/well of
construct encoding either WT or mutant pro-IL-1b
linked to GFP via an IRES sequence. IL-1b
secretion in each condition was subsequently
measured by ELISA (B). C284S mutant form of
Casp1 was included as a negative control for
Casp1 activity. The noncleavable D117A pro-IL-1b
mutant was additionally included as a negative
control. (C) IB analyses of the cells transfected in
(B) were performed to illustrate equal transfection
in the conditions.
(D) 293T cells seeded in 6-well plates were trans-
fected with 500 ng/well of each construct for
Myc-ASC, Streptag-Casp1, and WT or K133R
pro-IL-1b linked to GFP via IRES. 3 mg of expres-
sion plasmid encoding HA-tagged WT, K48R, or
K63R Ub was also included. 24 hr later, cells were
lysed and subjected to pro-IL-1b IP followed by IB
analyses for Ub signals and Casp1 association.
Input immunoblots are shown below.were removed by USP2 (Figures 4A–4C). We thus utilized anti-
G-G antibody-assisted mass spectrometry to find potential
ubiquitinated IL-1b peptides from LPS-stimulated Tnfaip3/
BMDMs. These analyses revealed that an evolutionarily
conserved K133 of mouse pro-IL-1b undergoes ubiquitination
(Figure 6A). As these studies were performed on endogenous
proteins in primary cells undergoing LPS stimulation, and as
K133 ubiquitination was detected repeatedly, the ubiquitina-
tion at this site is likely to be a dominant and physiological
event. To investigate the functional impact of pro-ILb ubiquiti-
nation, we generated a K133R mutant of pro-IL-1b and tested
its processing in 293T cells. Mutant K133R pro-IL-1b was
cleaved less efficiently than WT protein, leading to less secre-
tion of mature IL-1b (Figures 6B and 6C). As expected,
mutating the cleavage site of pro-IL-1b at D117 as well as
the catalytic site of Casp1 at C284 abolished pro-IL-1b pro-Immunity 42, 55–6cessing (Figures 6B and 6C). K133R
pro-IL-1b protein also exhibited less to-
tal, non-K48, and non-K63 ubiquitination
than WT pro-IL-1b (Figure 6D). By con-
trast, the non-cleavable D117A mutant
form of pro-IL-1b exhibited no obvious
defects in ubiquitination (Figure 6D).Thus, these data support the notion that pro-IL-1b ubiquitina-
tion at K133 promotes its proteolytic cleavage.
DISCUSSION
In this study, we have uncovered a role for A20 in restricting
NLRP3 inflammasome functions. A20-deficient macrophages
exhibit spontaneous NLRP3 activity to various stimuli that
are otherwise insufficient to induce pro-IL-1b processing in
normal cells. Interestingly, TLRs that only utilize MyD88 to
signal did not trigger this response. AIM2 (absent in melanoma
2) inflammasomes response to poly(dA:dT) in Tnfaip3/
cells were also normal following TLR2 or TLR7 priming (Figures
S4A and S4B). Hence, A20 might be particularly important
for preventing spontaneous NLRP3 activation by receptors
that share common components with TLR3 signaling. The7, January 20, 2015 ª2015 Elsevier Inc. 63
absence of DAMPs in the supernatants of stimulated
Tnfaip3/ cells suggests an intrinsic mechanism of NLRP3
activation.
We previously described an important role for A20 in restrict-
ing TLR-induced NF-kB signaling (Boone et al., 2004; Turer
et al., 2008), and a recent study showed that exaggerated
TLR-induced expression of inflammasome proteins causes
arthritis in mice lacking A20 in myeloid cells (Vande Walle
et al., 2014). Our current study, however, reveals that the spon-
taneous NLRP3 activity in A20-deficient cells does not correlate
entirely with the amount of NF-kB-induced pro-IL-1b or
NLRP3 protein. Hence, A20 likely restricts NLRP3 inflamma-
some activity via multiple mechanisms.
Genetic defects that lead to spontaneous IL-1b secretion by
innate immune cells have been reported in three other instances.
In one case, ablation of the Atg16L1 gene involved in autophagy
resulted in spontaneous NLRP3 activation by LPS alone (Saitoh
et al., 2008). In another, BMDMs from mice rendered deficient in
all three IAPs similarly exhibited spontaneous NLRP3 inflamma-
some activity (Vince et al., 2012). Most recently, loss of second
signal requirement for pro-IL-1b processing was reported for
Casp8-deficient DCs (Kang et al., 2013). The molecular mecha-
nisms by which Tnfaip3/ cells acquire spontaneous NLRP3
activity are likely to be distinct from these reported studies. First,
A20 deficiency exaggerates, not blunts, autophagic response to
LPS (Shi and Kehrl, 2010a; 2010b). Second, as observed here
and previously reported (Jin et al., 2009), Tnfaip3/ cells exhibit
increased Casp8 activity. While the spontaneous NLRP3 activity
of Tnfaip3/ cells resembles that of the IAP triple mutants (Vince
et al., 2012), marked differences in their responses are also
noted. As in IAP triple-deficient cells, RIPK3may drive NLRP3 in-
flammasome activation in Tnfaip3/ cells via ROS generation
(data not shown). However, unlike the IAP triple mutants, which
exhibit spontaneous pro-IL-1b processing in response to all TLR
ligands, A20-deficient cells selectively display this response
after TLR signals that utilize TRIF. Moreover, we found no evi-
dence for increased formation of RIPK1-RIPK3 complexes in
Tnfaip3/ cells after LPS stimulation. Whereas RIPK1 catalytic
activity is dispensable in IAP triple mutants, it appears necessary
for the spontaneous NLRP3 activity in Tnfaip3/ cells. Thus, our
studies build on the concept that RIPK3 supports NLRP3 inflam-
masome activation, but identify a pathway toward this outcome
that is inhibited by A20.
Using pro-IL-1b IPs, we have discovered that A20 exists in a
complex that contains Casp1, Casp8, RIPK1, and RIPK3 in
LPS-stimulated BMDMs. These protein interactions appear spe-
cific because (1) pull-downs using the isotype control antibody
failed to co-IP these proteins and (2) pro-IL-1b IPs from lysates
of unstimulated cells, which do not express any pro-IL-1b,
yielded little, if any, co-associated proteins. These results
suggest two potential mechanisms by which A20 suppresses
NLRP3 inflammasomes. First, the increased amounts of
Casp1, Casp8, and RIPK1 associating with pro-IL-1b in A20-
deficient cells indicate that A20 regulates the composition of
this complex. Second, as ubiquitination of pro-IL-1b complex
is increased in A20-deficient cells in response to LPS alone or
LPS plus ATP, these Ub chains might support pro-IL-1b
processing and subsequent secretion. Neither ASC deficiency
(data not shown) nor preventing K+ efflux affected the composi-64 Immunity 42, 55–67, January 20, 2015 ª2015 Elsevier Inc.tion or ubiquitination of the pro-IL-1b complex. Thus, both
ubiquitination and formation of this complex occur prior to
NLRP3-ASC inflammasome assembly.
We have observed increased Casp8 activity in A20-deficient
cells that tightly correlates with spontaneous IL-1b secretion.
Exaggerated Casp8 activity in LPS-stimulated A20-deficient
BMDMs might reflect A20’s ability to restrict Casp8 (Jin
et al., 2009). As Casp8 can cleave pro-IL-1b in the absence
of Casp1 (Bossaller et al., 2012; Gringhuis et al., 2012; Gurung
et al., 2014; Maelfait et al., 2008; Vince et al., 2012), the
observed residual IL-1b secretions by Tnfaip3/Casp1/11/
cells might reflect pro-IL-1b processing by Casp8. Additionally,
abolishing RIPK3 in A20-deficient cells reduced Casp8 activity,
as well as pro-IL-1b processing. A recent finding suggests that
Casp8 activity can prime and activate NLRP3 inflammasomes
(Gurung et al., 2014). It is thus tempting to speculate
that Casp8 activity initiates NLRP3 and Casp1 activation in
A20-deficient cells.
We have discovered the presence of K63-linked and unan-
chored poly-Ub in the pro-IL1b complex, both chain types
known to play critical roles in signal propagation (Corn and
Vucic, 2014; Xia et al., 2009). While K48-linked poly-Ub is also
present, the majority of K48 linkages appeared to be associated
with unanchored chains. Recently, K48 linkages in unanchored
or mixed Ub chains have been reported to propagate signaling
independently of the proteasomes (Jiang et al., 2012; Rajsbaum
et al., 2014). Thus, the presence of K63 linkages (and potentially,
K48 linkages in unanchored chains) in pro-IL1b complex sug-
gests that NLRP3 inflammasome activation involves ubiquitina-
tion, a step that A20 inhibits.
NLRP3, ASC, and Casp1 deficiency had no effects on the pro-
IL-1b-associated Ub signals in LPS-stimulated A20-deficient
cells. These observations indicate that this ubiquitination event
is distinct from those previously reported for Casp1 and ASC
during NLRP3 inflammasome activation (Labbe´ et al., 2011;
Rodgers et al., 2014). Our IP/IB, mass-spectrometry, and muta-
tional analyses revealed that K133 of mouse pro-IL-1b is ubiqui-
tinated and that ubiquitination of this site supports pro-IL-1b
proteolytic cleavage. IL-1b ubiquitination might support pro-
IL-1b cleavage by encouraging higher order oligomerization of
inflammasome components; future studies will be needed to
define this mechanism more precisely. Given the known roles
of ubiquitination in autophagy (Shaid et al., 2013), IL-1b ubiquiti-
nation could also potentially support IL-1b secretion through an
autophagy-based unconventional secretory pathway (Dupont
et al., 2011).
In summary, we have discovered that A20 plays a critical role
in preventing spontaneous NLRP3 inflammasome activation and
in limiting its activity by exogenous stimuli. Given the genetic
links of A20 to multiple human inflammatory diseases, our
findings establish links between A20, ubiquitination, inflamma-
somes, and human diseases.
EXPERIMENTAL PROCEDURES
Mice
Tnfaip3/, Nlrp3/, Asc/, Casp1/11/, Tnf/, and Ripk3/mutant mice
have been previously described. All mice used in this study were housed and
bred in a specific pathogen-free facility according to the IACUC guidelines
of UCSF.
BMDM Cultures and Treatments
Primary BMDMs were cultured from mouse femurs and tibia using standard
protocols described in Supplemental Experimental Procedures. For ELISAs,
cells were plated at 1–2 million cells in 0.5 ml per well in 24-well format. Innate
immune receptor ligands were purchased from InvivoGen. Anti-CD40 anti-
body, clone FGK4.5, was produced by the UCSF antibody core facility.
Recombinant murine TNF-a and Necrostatin-1 were purchased from R&D
Systems and Enzo Life Sciences, respectively. Supernatants were typically
harvested between 2–18 hr post-stimulation. To induce NLRP3 activation by
ATP, we primed BMDMs with LPS at 50–500 ng/mL for 4–16 hr and subse-
quently treated with PBS containing 5 mM ATP for 15–30 min as described
in Supplemental Experimental Procedures.
Protein Overexpression Analyses
293T cells were grown to 70%–80% confluence in DMEM containing 10%
FBS, Pen-Strep, and L-Glut before transfection using Lipofectamine LTX
without Plus Reagent (Invitrogen). The following full-length cDNA expression
plasmids were either generated using commercially available vectors or
purchased from the indicated vendors: Myc-DDK tagged ASC in pCMV6-
Entry (Origene); N-terminally HA-tagged Casp1 in pCMV-HA (Clonetech);
N-terminally StrepTagged mouse Casp1 in pCMV-Script (Stratagene); Full-
length IL-1b in pIRES2-AcGFP (Clontech); N-terminally Flag-tagged A20 in
pCMV-Tag2 (Stratagene). 33 HA-tagged WT Ub, K63-only Ub, K48R Ub,
and K63R Ub pcDNA3.1 constructs were kind gifts from Dr. Vishva Dixit (Gen-
entech). Cells were typically transfected in 6-well format in 2 ml media with
150 ng/well of each vector, except for Ub constructs (which were used at
3 mg/well) and A20 (which varied from 0 to 50 ng/well).
ELISAs and LDH Release Assays
IL-1b (BD Biosciences) and IL-18 (eBioscience) ELISAs and LDH release
assays (Cytotoxicity Detection Kit, Roche Life Science) were performed per
manufacturer’s instructions.
Immunoblotting and Immunoprecipitation
IB and IP analyses were performed using standard protocols described in
Supplemental Experimental Procedures.
DUB Assays
Five 10-cm plates of Tnfaip3/ cells (corresponding to 2 3 108 cells) were
stimulated with 500 ng/mL LPS for 6 hr. Cells were lysed, and IL-1b
IPs were performed in five separate tubes as described in Supplemental
Experimental Procedures. During the last wash, the beads containing IL-
1b-associated Ub complex were combined, split into several equal aliquots,
and subjected to DUB treatments using protocols similar to those included
in the UbiCREST kit (Boston Biochem) as detailed in Supplemental Experi-
mental Procedures.
Pro-IL-1b Ubiquitination Site Determination
Day-6 Tnfaip3/BMDMswere seeded in twenty 15-cm plates and stimulated
with 500 ng/mL LPS for 6 hr as described above. Subsequently, the cells were
lifted using PBS containing 5 mM EDTA, pooled, centrifuged, and snap-frozen
upon removal of PBS. The frozen cells were then subjected to lysis, followed
by anti-Gly-Gly immunoprecipitation and UbiScan-assisted mass spectro-
metric analyses as detailed in Supplemental Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures and Supplemental Experi-
mental Procedures and can be found with this article online at http://dx.doi.
org/10.1016/j.immuni.2014.12.031.
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